Sep 17, 2024 20:29
KAPA - Kairos Pharma, Ltd.
| Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
|---|---|---|---|---|---|---|---|
| 1.28 -0.03 (-2.34%) | --- | 0.0 (0.0%) | 0.0 (0.0%) | 0.02 (1.6%) | -0.06 (-4.58%) | 0.03 (2.46%) | 0.03 (2.46%) |
Kairos Pharma Ltd is a clinical-stage biopharmaceutical company. It is engaged in therapeutics for cancer patients that are designed to overcome key hurdles in immune suppression and drug resistance. These therapeutics include antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma.
Category:
PHARMACEUTICAL PREPARATIONS
Market Period:
Closed
Earnings & Ratios
- Basic EPS:
- -0.08
- Diluted EPS:
- -0.08
- Basic P/E:
- -15.625
- Diluted P/E:
- -15.625
- RSI(14) 1m:
- 100.0
- VWAP:
- 1.25
- RVol:
- 0.3901
Events
| Period | Kind | Movement | Occurred At |
|---|---|---|---|
| 1m | Price decrease 1m | 1.24 -0.01 (-1.2%) | Oct 15 15:58 |
| 1m | Price decrease 1m | 1.25 -0.02 (-1.97%) | Oct 15 15:47 |
| 1m | Price decrease 1m | 1.25 -0.02 (-1.57%) | Oct 15 09:57 |
| 60m | Price increase 60m | 1.36 +0.07 (+5.43%) | Oct 15 05:19 |